Like cytokines and other mediators of the immune system, MPs have pleiotropic actions and can affect multiple steps in disease pathogenesis ... or arthrocentesis in RA. Selective therapies ...

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...

As a small molecule drug, it works by modulating the immune response and reducing inflammation, which are key factors in the pathophysiology of RA. Recent research has focused on its efficacy ...

Objective Metabolic reprogramming plays a critical role in modulating the innate and adaptive immune response, but its role ...

suggesting that leptin may play a crucial role in the pathophysiology of RA[1]. Similarly, another study highlighted the pro-inflammatory effects of adiponectin in RA, showing increased expression ...

Q: Is Ra.One Flop or Hit? A: The performance of Ra.One was Hit. Q: What is the overall Box Office Collection of Ra.One? A:Ra.One collected ₹203.95 cr. at the worldwide box office. In India ...

Autoimmune diseases represent a significant challenge in the field of medicine, as they occur when the immune system erroneously targets the body's own ...

Objective In 2011, the American College of Rheumatology (ACR) and EULAR endorsed provisional criteria for remission in rheumatoid arthritis (RA), both Boolean-based and index-based. Based on recent ...

Background Despite treatment according to the current management recommendations, a significant proportion of patients with rheumatoid arthritis (RA) remain symptomatic. These patients can be ...

In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...